89.98

3.45% 3.00

After Hours: 89.98

Transmedics Group Inc (TMDX)

Overview News Price History Option Chain Financials Why TMDX Down? Discussions Forecast

Transmedics Group Inc stock is traded at $89.98, with a volume of 542.55K. It is up +3.45% in the last 24 hours and up +11.43% over the past month. TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Previous Close:

$86.98

Open:

$84.63

24h Volume:

542.55K

Relative Volume:

0.58

Market Cap:

$3.12B

Revenue:

$635.89M

Net Income/Loss:

$171.92M

P/E Ratio:

20.65

EPS:

4.357

Net Cash Flow:

$151.36M

1W Performance:

+1.75%

1M Performance:

+11.43%

6M Performance:

-39.06%

1Y Performance:

-13.52%

1-Day Range:

$83.61

$90.11

1-Week Range:

$81.34

$90.11

52-Week Range:

$60.10

$156.00

Transmedics Group Inc Stock (TMDX) Company Profile

Name

Transmedics Group Inc

Sector

Healthcare (1074)

Industry

Medical Devices (141)

Phone

(978) 552-0900

Address

200 MINUTEMAN ROAD, ANDOVER, MA

Employee

898

Twitter

@transmedics

Next Earnings Date

2026-08-04

Latest SEC Filings

TMDX's Discussions on Twitter

Compare TMDX vs ABT, MDT, SYK, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TMDX Transmedics Group Inc	89.98	3.15B	635.89M	171.92M	151.36M	4.357
ABT Abbott Laboratories	108.33	197.51B	46.59B	5.41B	7.38B	3.0938
MDT Medtronic Plc	94.17	118.14B	36.36B	4.84B	5.43B	3.7261
SYK Stryker Corp	303.13	125.70B	25.27B	3.34B	4.57B	8.6334
BSX Boston Scientific Corp	47.80	71.55B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	89.90	51.78B	6.30B	1.07B	1.09B	1.8406

Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-23-25	Upgrade	Needham	Hold → Buy
Oct-13-25	Initiated	Jefferies	Buy
Sep-16-25	Initiated	Evercore ISI	Outperform
Sep-04-25	Initiated	Stifel	Hold
Dec-17-24	Downgrade	JP Morgan	Overweight → Neutral
Nov-22-24	Downgrade	Needham	Buy → Hold
Oct-29-24	Reiterated	Needham	Buy
Oct-29-24	Reiterated	Oppenheimer	Outperform
Sep-24-24	Initiated	Robert W. Baird	Outperform
Aug-21-24	Initiated	Needham	Buy
Jun-06-24	Initiated	Cantor Fitzgerald	Overweight
Jun-04-24	Initiated	Stephens	Overweight
Mar-28-24	Initiated	Piper Sandler	Overweight
Jul-19-23	Initiated	Robert W. Baird	Outperform
Aug-02-22	Upgrade	JP Morgan	Neutral → Overweight
Oct-08-20	Downgrade	JP Morgan	Overweight → Neutral
Apr-07-20	Initiated	Oppenheimer	Outperform
May-28-19	Initiated	Canaccord Genuity	Buy
May-28-19	Initiated	Cowen	Outperform
May-28-19	Initiated	JP Morgan	Overweight
May-28-19	Initiated	Morgan Stanley	Equal-Weight

View All

Transmedics Group Inc Stock (TMDX) Latest News

03:13 AM

Law firm probes TransMedics officers for possib... - Pluang

03:13 AM

03:03 AM

Did TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PR Newswire

03:03 AM

Sep 06, 2026

Jupiter Topco LLC Makes New Investment in TransMedics Group, Inc. $TMDX - MarketBeat

Sep 06, 2026

Sep 05, 2026

The Manufacturers Life Insurance Company Acquires Shares of 17,159 TransMedics Group, Inc. $TMDX - MarketBeat

Sep 05, 2026